Ukuqonda Okusha Ngezinhlobo Ezincane Zezakhi Zofuzo Zabantu Abadala B-ALL

15 Januwari 2025, eShanghai - Isibuyekezo sakamuva esishicilelwe kumagazini Igazi inikeza ukuhlaziywa okujulile kwezinhlobo zezakhi zofuzo ze-B-cell Acute Lymphoblastic Leukemia (B-ALL) yabantu abadala, isifo esingavamile nesinolaka esinomphumela ongemuhle kakhulu kubantu abadala uma kuqhathaniswa nezingane. Eminyakeni engamashumi amabili edlule, ucwaningo lwezakhi zofuzo luthole izinhlobo zezakhi zofuzo ezingaphezu kuka-20 ezihlukile ze-B-ALL, ngayinye inemiphumela ehlukile ekwelashweni nasekubikezelweni.

Nakuba izindlela zokwelapha ezivumelaniswe nezingozi zofuzo ziye zashintsha amasu okwelapha ku-B-ALL yezingane, isimo sofuzo se-B-ALL yabantu abadala asikaqondakali kahle. Lokhu kubuyekezwa kugqamisa ukuqonda okubalulekile ngokuhlukahluka kwezinto eziphilayo zezinhlobo zofuzo ezigulini ezindala futhi kugcizelela isidingo sokuhlanganisa ukuhlonza izakhi zofuzo ekuxilongweni okuvamile ukuze kuvunyelwe amasu okwelapha aqondene nomuntu ngamunye.

Okutholakele Okubalulekile:

1. I-Philadelphia Chromosome-Positive (Ph+) B-ALL:
   Okumele uhlobo oluvame kakhulu kubantu abadala, ikakhulukazi kulabo abaneminyaka engaphezu kwengu-55, i-Ph+ B-ALL ivela ku-BCR::ABL1 fusion gene. Ngokomlando kuhlotshaniswa nokubikezela okubi, ukuhlanganiswa kwama-tyrosine kinase inhibitors (TKIs) kanye nama-antibody e-monoclonal aqondisiwe, njenge-blinatumomab, kuye kwathuthukisa kakhulu amazinga okusinda. Ubufakazi obuvelayo buveza ukungafani okukhulu kwezinto eziphilayo ngaphakathi kwe-Ph+ B-ALL, okugcizelela ukubaluleka kwezimpawu zama-molecule njenge-IKZF1 zokuhlukaniswa kwezingozi kanye nokuhlela ukwelashwa.

2. Izinguquko ze-Hypodiploidy eziphansi kanye ne-TP53:
   I-hypodiploidy ephansi, ebonakala ngokubalwa kwama-chromosome angu-30-39, ivame kakhulu kubantu abadala futhi ihambisana nemiphumela emibi. Izifundo zakamuva ziqokomisa indima yezinguquko ze-TP53, ezivame ukuhlotshaniswa ne-clonal hematopoiesis, ekuqhubeni lolu hlobo oluyingozi kakhulu. Okutholakele kusikisela ukuthi lezi zinguquko azithinti nje kuphela ukuqala kwesifo kodwa zingase futhi zinikeze ulwazi ngamasu okwelapha ngemva kokukhululwa.

3. Ukuhlelwa kabusha kwe-KMT2A:
   Okuvame ukubonwa kubantu abadala i-B-ALL, ukuhlelwa kabusha kwe-KMT2A kuhlotshaniswa nemiphumela emibi. Izindlela zokwelapha ezintsha, njengezithibi ze-menin, zinesithembiso sokubhekana nokumelana kokwelashwa okungokwemvelo kwalolu hlobo.

4. Izinhlobo Ezingavamile kanye Nezindlela Zokwelapha Ezisafufusa:
   Izinhlobo ezincane ezifana nokuhlanganiswa kwe-TCF3::PBX1 kanye ne-TCF3::HLF, yize kungavamile, zibonisa ukwehlukahluka okukhulu kwezinto eziphilayo kanye nezokwelapha. Ukukhuthaza idatha yangaphambi kokwelashwa kusikisela ukuzwela kuma-ejenti amasha afana ne-venetoclax kanye ne-BET inhibitors, okuvula indlela yezinketho zokwelapha ezintsha.

Imiphumela Yezokwelapha:

Ukubuyekezwa kudinga ukufakwa njalo kwamasu athuthukisiwe okuhlola izakhi zofuzo, okuhlanganisa nokulandelana kokubhalwa kwezakhi zofuzo okuphelele, ukuze kutholakale izinhlobo ezithile zezakhi zofuzo ze-B-ALL yabantu abadala. Le ndlela ingathuthukisa ukuhlukaniswa kwezingozi, iqondise izinqumo zokwelapha, futhi ithuthukise ukuqapha izifo ezincane ezisele (MRD).